siRNA treatment decreases triglycerides in patients with uncommon health condition

.RESEARCH HIGHLIGHT.19 September 2024.

Plozasiran lessened triglyceride levels through 80% and decreased the danger of pancreatitis in patients with consistent chylomicronemia, with or even without a hereditary diagnosis.